II. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: co-milling.
Lauretta Maggi, Giovanna Bruni, Mariarosa Maietta, Andrea Canobbio, Andrea Cardini, Ubaldo Conte
Index: Int. J. Pharm. 454(1) , 568-72, (2013)
Full Text: HTML
Abstract
Nateglinide is an oral antidiabetic agent that should be administered 10-30 min before the meal, but it shows low and pH-dependent solubility that may reduce its oral bioavailability. To improve nateglinide dissolution rate, the active was co-milled with three different super-disintegrants or with some hydrophilic excipients, in 1:1, 1:2, and 1:4 drug to carrier ratio (w:w). The three super-disintegrants were crosslinked polyvinylpyrrolidone (PVPC), sodium starch glycolate (SSG) and crosslinked carboxymethyl cellulose (CMCC). The three hydrophilic excipient were amorphous silica (AS), mannitol (M) and Poloxamer (PO). A strong enhancement of drug dissolution rate was obtained from the nateglinide:super-disintegrant co-milled systems in 1:4 ratio, which can be explained by a combination of several factors: an increase in wettability, due to the hydrophilic nature of the carriers, a possible reduction of particle size and a more intimate dispersion of the drug onto the carrier, as a result of the mechanical treatment.Copyright © 2013 Elsevier B.V. All rights reserved.
Related Compounds
Related Articles:
2013-11-01
[Pak. J. Pharm. Sci. 26(6) , 1229-35, (2013)]
From evidence assessments to coverage decisions?: the case example of glinides in Germany.
2012-01-01
[Health Policy 104(1) , 27-31, (2012)]
Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.
2005-10-01
[Int. J. Clin. Pract. 59(10) , 1218-28, (2005)]
2012-02-01
[Diabetes Obes. Metab. 14(2) , 187-9, (2012)]
Nateglinide (Starlix): update on a new antidiabetic agent.
2003-01-01
[Int. J. Clin. Pract. 57(6) , 535-41, (2003)]